Errata: Effectiveness and Adverse Events of Tolvaptan in Octogenarians With Heart Failure

Interim Analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study)

Abstract

The following errors appeared in the article titled “Effectiveness and Adverse Events of Tolvaptan in Octogenarians With Heart Failure : Interim Analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study)” by Koichiro Kinugawa, Takayuki Inomata, Naoki Sato, Moriyoshi Yasuda, Toshiyuki Shimakawa, Kosuke Bando, Kazuki Mizuguchi (Vol. 56, No. 2, 137-143, 2015).
In Table I, the values of “Aldosterone antagonist, (%)” in “All patients”, “7” should be replaced by “44”, in “U-80”, “9” by “49”, in “Aged”, “5” by “39”, and in “P”, “0.0025^**” by “< 0.0001^***”.
The corrected table is given below;